adjust ep exclud certain amort restructur one-tim item
zoeti locat parsippani nj world largest anim health compani medicin product
novemb zoeti report strong result revenu adjust ep vs
rais ep estim per share midpoint improv guidanc
pet drive growth zoeti big three product apoquel simparica cytopoint
help drive growth companion anim exclud partial quarter abaxi
abaxi portfolio would grown double-digit pro forma distributor de-stock neg impact
continu base companion busi face volum declin due competit though
partial off-set price overal price across speci grew compani expect
sustain price in-lin ytd growth
livestock updat livestock driven poultri swine fish
poultri expect outpac broader livestock market swine in-lin cattl declin
due pressur dairi beef market cattl market expect grow rate
overal livestock posit signal indic potenti recoveri sometim next year
margin improv oper margin grew larg driven improv gross
margin zoeti invest intern sale invest expect
continu along integr abaxi beyond compani anticip oper
expens grow rate closer inflat expect oper margin improv
repres approxim expans annual
continu recommend zoeti best-in-class anim health compani establish track record
out-performance sinc go public valuat certainli rich nearli ebitda estim
still low end valuat spectrum us-trad peer anim health opportun
dermatolog portfolio abaxi could provid upsid estim current trade
discount pmv per share
million except per share
exclud certain non-cash item restructur certain one-tim item
compani file research estim
million except per share
current market discount pmv
after-tax payment buy option pmv
compani file research estim
kevin kedra research analyst prepar report herebi certifi view express report accur reflect
analyst person view subject compani secur research analyst
receiv direct indirect compens express specif recommend view report
public data novemb rate buy
